v3.26.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net income $ 2,751,952 $ 815,689
Adjustments to reconcile net income to net cash used in operating activities:    
Dividend earned on marketable securities held in Trust Account (3,174,275) (1,165,212)
Compensation expense to directors 108,750
Change in fair value of over-allotment liability (587)
Changes in operating assets and liabilities:    
Prepaid expense 15,261 (184,814)
Accounts payable and Accrued expenses 3,895 330
Net cash used in operating activities (403,167) (425,844)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (115,000,000)
Net cash used in investing activities (115,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 112,700,000
Proceeds from sale of Private Placement Units 3,800,000
Proceeds from promissory note - related party 156,900
Repayment of promissory note - related party (175,000)
Payment of offering costs (75,000) (339,005)
Net cash (used in) provided by financing activities (75,000) 116,142,895
Net Change in Cash (478,167) 717,051
Cash – Beginning of period 666,920
Cash – End of period 188,753 717,051
Supplemental disclosure of cash flow information:    
Deferred offering costs included in accrued offering costs 75,000
Remeasurement of Class A ordinary shares to redemption value 3,174,275 10,395,953
Deferred underwriting fee payable 4,025,000
Advances from related party paid through promissory note – related party 18,100
Over-allotment liability at upon full exercise $ 127,215